Jan 1, 2026 · Asciminib is used to treat Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP) in patients who are newly diagnosed or who have …

Asciminib is an ABL/BCR-ABL1 tyrosine kinase inhibitor. Asciminib inhibits the ABL1 kinase activity of the BCR::ABL1 fusion protein, by binding to the ABL myristoyl pocket.

Asciminib, sold under the brand name Scemblix, is a medication used to treat Philadelphia chromosome -positive chronic myeloid leukemia (Ph+ CML). [5][7][8] Asciminib is a protein …

Mar 13, 2025 · What is asciminib? Asciminib is used in adults to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (CML). Asciminib is …

Learn more about SCEMBLIX® (asciminib) tablets, a treatment for adults with Ph+ CML in chronic phase. See full Prescribing and Safety Information.

Asciminib, a BCR::ABL1 inhibitor specifically targeting the ABL myristoyl pocket, may offer better efficacy and safety and fewer side effects than currently available frontline ATP-competitive...

Asciminib is a first-in-class allosteric inhibitor of the kinase activity of BCR::ABL1, specifically targeting the ABL myristoyl pocket (STAMP). This review focuses on the pharmacokinetic (PK) …

This page contains brief information about asciminib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Asciminib is an ABL/BCR-ABL1 tyrosine kinase inhibitor. Asciminib inhibits the ABL1 kinase activity of the BCR::ABL1 fusion protein, by binding to the ABL myristoyl pocket.

Dec 12, 2022 · Asciminib Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, …